EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Enhanced Migration of Fuchs Corneal Endothelial Cells by Rho Kinase Inhibition: A Novel Ex Vivo Descemet’s Stripping Only Model

Mohit Parekh iD, Annie Miall iD, Ashley Chou, Lara Buhl, Neha Deshpande, Marianne O Price iD, Francis W Price, Ula V Jurkunas

Cells · 19.07.2024 · 13 (14) · 1218

DOI: 10.3390/cells13141218 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, online erschienen am 19.07.2024. Verfasst von Mohit Parekh und 7 weiteren Autor:innen. Beteiligte Einrichtung: Schepens Eye Research Institute of Mass Eye and Ear, Department of Ophthalmology, Harvard Medical School, 20 Staniford Street, Boston, MA 02114, USA. Hauptthemen laut MEDLINE: rho-Associated Kinases, Cell Movement, Fuchs' Endothelial Dystrophy. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kowa company ltd..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Descemet’s Stripping Only (DSO) is a surgical technique that utilizes the peripheral corneal endothelial cell (CEnC) migration for wound closure. Ripasudil, a Rho-associated protein kinase (ROCK) inhibitor, has shown potential in DSO treatment; however, its mechanism in promoting CEnC migration remains unclear. We observed that ripasudil-treated immortalized normal and Fuchs endothelial corneal dystrophy (FECD) cells exhibited significantly enhanced migration and wound healing, particularly effective in FECD cells. Ripasudil upregulated mRNA expression of Snail Family Transcriptional Repressor (SNAI1/2) and Vimentin (VIM) while decreasing Cadherin (CDH1), indicating endothelial-to-mesenchymal transition (EMT) activation. Ripasudil activated Rac1, driving the actin-related protein complex (ARPC2) to the leading edge, facilitating enhanced migration. Ex vivo studies on cadaveric and FECD Descemet’s membrane (DM) showed increased migration and proliferation of CEnCs after ripasudil treatment. An ex vivo DSO model demonstrated enhanced migration from the DM to the stroma with ripasudil. Coating small incision lenticule extraction (SMILE) tissues with an FNC coating mix and treating the cells in conjunction with ripasudil further improved migration and resulted in a monolayer formation, as detected by the ZO-1 junctional marker, thereby leading to the reduction in EMT. In conclusion, ripasudil effectively enhanced cellular migration, particularly in a novel ex vivo DSO model, when the stromal microenvironment was modulated. This suggests ripasudil as a promising adjuvant for DSO treatment, highlighting its potential clinical significance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

rho-Associated KinasesCell MovementFuchs' Endothelial DystrophyHumansIsoquinolinesSulfonamidesEndothelial CellsEndothelium, CornealDescemet MembraneEpithelial-Mesenchymal TransitionProtein Kinase InhibitorsDescemet Stripping Endothelial KeratoplastyCell ProliferationModels, BiologicalWound Healing

Stichwörter der Autor:innen

Descemet’s Stripping OnlyFuchs endothelial corneal dystrophyROCK inhibitorcellscorneacorneal endotheliummigration

Substanzen

rho-Associated KinasesK-115IsoquinolinesSulfonamidesProtein Kinase Inhibitors

Autor:innen und Institutionen

  • Schepens Eye Research Institute of Mass Eye and Ear, Department of Ophthalmology, Harvard Medical School, 20 Staniford Street, Boston, MA 02114, USA.
  • Faculty of Arts and Sciences, Harvard College, Boston, MA 02138, USA.
  • Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA 02114, USA.
  • Cornea Research Foundation of America, Indianapolis, IN 46260, USA.
  • Cornea and Refractive Surgery Service, Massachusetts Eye and Ear Infirmary, 243 Charles Street, Boston, MA 02114, USA.

ORCID-Profile: Mohit Parekh, Annie Miall, Marianne O Price

Förderung

  • Kowa company ltd.

Zitieren

APA

Parekh, M., Miall, A., Chou, A., Buhl, L., Deshpande, N., Price, M. O., Price, F. W., & Jurkunas, U. V. (2024). Enhanced Migration of Fuchs Corneal Endothelial Cells by Rho Kinase Inhibition: A Novel Ex Vivo Descemet’s Stripping Only Model. Cells, 13(14), 1218. https://doi.org/10.3390/cells13141218

Vancouver

Parekh M, Miall A, Chou A, Buhl L, Deshpande N, Price MO, et al. Enhanced Migration of Fuchs Corneal Endothelial Cells by Rho Kinase Inhibition: A Novel Ex Vivo Descemet’s Stripping Only Model. Cells. 2024;13(14):1218. doi:10.3390/cells13141218

BibTeX
@article{Parekh2024,
  author = {Parekh, Mohit and Miall, Annie and Chou, Ashley and Buhl, Lara and Deshpande, Neha and Price, Marianne O and Price, Francis W and Jurkunas, Ula V},
  title = {Enhanced Migration of Fuchs Corneal Endothelial Cells by Rho Kinase Inhibition: A Novel Ex Vivo Descemet’s Stripping Only Model},
  journal = {Cells},
  year = {2024},
  volume = {13},
  number = {14},
  pages = {1218},
  doi = {10.3390/cells13141218}
}
Kostenlos starten →